| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Richard Wadley CEO | OTC PINK Exchange | 53215R100 CUSIP |
| US Country | 52 Employees | - Last Dividend | - Last Split | - IPO Date |
LifePoint, Inc., originally established as US Drug Testing, Inc. in 1992, underwent a significant rebranding in February 1998 when it adopted its current name. Based in Ontario, California, LifePoint, Inc. is engaged in the development, manufacturing, and sales of the IMPACT Test System, an advanced diagnostic testing and screening device tailored for a diverse range of markets including workplaces, ambulances, pharmacies, law enforcement agencies, and home health care. The company has positioned itself as a pivotal player in the diagnostic and health care arena, leveraging cutting-edge technology to facilitate timely and efficient health care solutions.
A cornerstone product of LifePoint, Inc., the IMPACT Test System is a sophisticated diagnostic testing and screening device designed to serve a wide array of sectors. This includes workplaces, where it plays a vital role in employee health screening; ambulances, offering rapid diagnostics in emergency scenarios; pharmacies, providing accessible health screenings for the general public; law enforcement agencies, where it aids in drug testing and other forensic needs; and home health care settings, enhancing patient care with at-home diagnostic capabilities. The versatility and reliability of the IMPACT Test System underscore LifePoint's commitment to delivering high-quality, innovative health care solutions.